Durvalumab for Non-Resectable Stage IIIB Non-Small Cell Lung Cancer—a Small Step or a Big Leap?
Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2018.03.18
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
AME Publishing Company